OpenVSafe by OpenVAERS
Search V-safe

WVY-25929-28876

3 vaccinations 4 coded responses 9 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
774 / TX
Registered
2021-01-15
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-15
    Registered in v-safe
  2. 2021-01-15
    Dose 1 — Moderna
  3. 2021-01-15
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Diarrhea
    Adult check-in
  5. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-12
    Dose 2 — Moderna
  8. 2021-02-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Palpitations — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Heart palpitations
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-08-13
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  10. 2022-01-11
    Dose 3 — Pfizer-BioNTech
  11. 2022-02-13
    Survey response — 12 months, dose 2
    MedDRA: Vertigo — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Vertigo
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-02-13
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  13. 2022-02-17
  14. 2022-02-22
  15. 2022-07-12
    Survey response — 6 months, dose 3
    MedDRA: Ageusia, Anosmia, Arthralgia, Pain in extremity, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Arthritis type symptoms in hands. Haven't been able to smell or taste that good since booster #1. Never tested positive for Covid.
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-07-12
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  17. 2022-07-13
    Call successful
    Does not wish to fill out VAERS report
  18. 2022-07-13
    Call successful
    Does not wish to fill out VAERS report
  19. 2023-01-11
    Survey response — 12 months, dose 3
    MedDRA: Chronic sinusitis, Sinus operation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    MedDRA releases: 2024-11
  20. 2023-01-11
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  21. 2023-01-12
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-01-15Moderna
22021-02-12Moderna
32022-01-11Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-02-13 Successful
2022-07-13
Does not wish to fill out VAERS report
2022-07-12 Successful
2022-07-13
Does not wish to fill out VAERS report
2023-01-11 Successful
2023-01-12
Participant prefers to complete VAERS report online

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-13

Systemic reaction (other): Heart palpitations

Release 11 — 12 months, dose 2

2022-02-13

Symptoms: Vertigo

Release 12 — 6 months, dose 3

2022-07-12

Symptoms: Arthritis type symptoms in hands. Haven't been able to smell or taste that good since booster #1. Never tested positive for Covid.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia · · ✓
SDAnosmia · · ✓
SDArthralgia · · ✓
SDChronic sinusitis · · ✓
SDPain in extremity · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSinus operation · · ✓
SDVertigo · · ✓
SROPalpitations ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release